Epsilon M&A Deal Report - Dexo
Transaction Multiples for the Valuation of Private Companies
BioProgress / Dexo
No EMAT :
17261
Announced Date :
26/12/2005
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
BioProgress
Target :
Dexo
Country :
France
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Food Producers > Food & Beverage Industry > Food Complements
Business Description :
Dexo manufactures, markets and distributes branded pharmaceuticals , for a range of different therapeutic indications, to pharmacies and hospitals in France > Specialises in medicines to treat...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
|
|
|
|
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
- Number of EMAT Reports / sub-sector « Food Complements » = 123
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/05/2006 | Private Group Led by Capiton AG | H. von Gimborn | Germany | ** | 17260 |
| 23/11/2006 | Nordic Health | Eurovita | Norway | * | 17259 |
Source: Epsilon Research / EMAT
